BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• 

  Job Trends

  Cambridge’s 30-Person Cure Forward to Dissolve This Week

  June 5, 2017

   · 

  2 min read
• 

  Drug Development

  Unknown Nanjing Legend Emerges as a CAR-T Phenom at ASCO

  June 5, 2017

   · 

  3 min read
• Drug Development

  Further Study Of Combination Of Eisai Inc.'s Lenvatinib And Merck & Co.'s Pembrolizumab In Previously Treated Patients With Metastatic Endometrial Cancer Supported By Interim Analysis Of Ongoing Phase Ib/II Trial

  June 5, 2017

   · 

  16 min read
• Drug Development

  ARMO BioSciences Announces Encouraging Survival Data Observed In Patients With Advanced Pancreatic Cancer In Phase I/Ib Trial Of Immunotherapy AM0010

  June 5, 2017

   · 

  6 min read
• Drug Development

  Halozyme Phase II Data In Advanced Pancreas Cancer Featured In An Oral Presentation At ASCO

  June 5, 2017

   · 

  6 min read
• Biotech Beach

  Poseida Therapeutics Presents High-Fidelity Genome Editing System For Production Of Allogeneic “Universal Donor” CAR-T Cells At ASCO Annual Meeting

  June 5, 2017

   · 

  4 min read
• Deals

  Innate Pharma Regroups From Trial Failure With €410 Million Deal For Novo Nordisk A/S’s AntiC5aR Antibody

  June 5, 2017

   · 

  9 min read
• Drug Development

  AstraZeneca PLC Release: LYNPARZA (Olaparib) Significantly Reduces The Risk Of Disease Worsening Or Death In Patients With BRCA-Mutated Metastatic Breast Cancer

  June 5, 2017

   · 

  12 min read
• Drug Development

  Hennepin Life Sciences Presents Pre-Clinical Data Showing Anti-Microbial Activity Of Glycerol Monolaurate In Preventing And Treating Catheter-Associated Urinary Tract Infections

  June 5, 2017

   · 

  5 min read
• Pharm Country

  Ymabs Announces Positive Topline Result In Pivotal Study Of Burtomab In Refractory Leptomeningeal Metastasis From Neuroblastoma

  June 5, 2017

   · 

  2 min read